English | Español

Technology/Innovation
+ Technology/Innovation
Patient Daily reports | Feb 23, 2021

NeuroRx plans to file for emergency use authorization for Zyesami
+ Technology/Innovation
Press release submission | Feb 21, 2021

KYOWA KIRIN: Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis
+ Technology/Innovation
Patient Daily reports | Feb 15, 2021

NeuroRx CEO says Zyesami trial shows promising results for critically ill COVID-19 patients
+ Technology/Innovation
Bree Gonzales | Feb 12, 2021

Aviptadil helped doctor who contracted COVID-19 avoid lung transplant
+ Technology/Innovation
Bree Gonzales | Feb 12, 2021

Great Plains Health patients treated with Zyesami (aviptadil) show signs of recovery from COVID-19
+ Technology/Innovation
Press release submission | Feb 12, 2021

ROCHE: Receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients
+ Technology/Innovation
Press release submission | Feb 12, 2021

CARE CAP PLUS: Offers Solution to Benefit Patients and Doctors
+ Technology/Innovation
Bree Gonzales | Feb 12, 2021

Zyesami (Aviptadil) helped speed recovery for GPH COVID patient

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes